Scientists test common bacteria as a weapon to target pancreatic tumors
[ad_1] Pancreatic cancer has proved one of the most deadly forms of the disease, and the most difficult to crack. It shrugs off immunotherapy drugs and resists chemotherapy, and only about 10% of patients live longer than five years after diagnosis. But Albert Einstein College of Medicine immunologist and microbiologist Claudia Gravekamp is trying a…